Red Flags for Insomnia

Critical Warning Signs Requiring Immediate Evaluation

The American Academy of Sleep Medicine suggests that sleepiness, or the tendency to fall asleep involuntarily, is uncommon in chronic insomnia and suggests an alternative sleep disorder, such as obstructive sleep apnea, narcolepsy, or periodic limb movement disorder 1, 2
The American Academy of Sleep Medicine indicates that fatigue, or low energy, tiredness, and weariness, is the expected daytime consequence of insomnia, not true sleepiness 1
Investigating the frequency, duration, and timing of naps, including both voluntary and involuntary episodes, is warranted, according to the American Academy of Sleep Medicine 1

The American Academy of Sleep Medicine states that patients with psychiatric disorders or chronic pain have insomnia rates of 50-75%, requiring bidirectional evaluation 3, 4
Sleep complaints may herald the onset of mood disorders or exacerbation of existing comorbid conditions, according to the American Academy of Sleep Medicine 1, 5

The American Academy of Sleep Medicine notes that stimulants, such as caffeine, methylphenidate, amphetamines, cocaine, and ephedrine derivatives, can contribute to insomnia 1, 4
Antidepressants, including SSRIs, SNRIs, and MAO inhibitors, can also contribute to insomnia, according to the American Academy of Sleep Medicine 1, 4
Cardiovascular agents, such as β-blockers, α-receptor agents, and diuretics, can contribute to insomnia, as stated by the American Academy of Sleep Medicine 1, 4
Pulmonary medications, including theophylline and albuterol, can also contribute to insomnia, according to the American Academy of Sleep Medicine 1, 4
Narcotic analgesics, such as oxycodone, codeine, and propoxyphene, can contribute to insomnia, as noted by the American Academy of Sleep Medicine 1, 4
Alcohol use or withdrawal can also contribute to insomnia, according to the American Academy of Sleep Medicine 1, 4

The American Academy of Sleep Medicine suggests that patients with dangerous occupations, such as driving or operating machinery, require special caution when taking sedative-hypnotics 1
Mental inefficiency, difficulty remembering, impaired attention, and difficulty with complex tasks beyond typical insomnia complaints can be indicative of cognitive and mood deterioration, according to the American Academy of Sleep Medicine 1, 4
Severe irritability, loss of interest, or depression disproportionate to sleep loss can also be indicative of cognitive and mood deterioration, as stated by the American Academy of Sleep Medicine 1, 4
Quality of life deterioration leading to avoidance of social activities, exercise, or work can be a consequence of insomnia, according to the American Academy of Sleep Medicine 1, 4

The American Academy of Sleep Medicine identifies SSRIs, including sertraline, as common contributors to insomnia, which can be exacerbated by concurrent use of atomoxetine 6.
Beta-blockers like propranolol are recognized contributors to insomnia, according to the American Academy of Sleep Medicine, and alternative agents like ACE inhibitors or calcium channel blockers may avoid this sleep disruption 6, 7.

The concurrent use of Zoloft (sertraline) with atomoxetine can significantly worsen sleep-disrupting effects through multiple mechanisms, including increased noradrenergic activation and serotonin-2 (5-HT2) receptor stimulation 6.
Paroxetine, another SSRI, is a CYP2D6 inhibitor that can increase atomoxetine exposure, similar to poor metabolizers, potentially leading to higher rates of insomnia 6, 7.

Polypharmacy with multiple sleep-disrupting agents, such as atomoxetine, sertraline, and propranolol, can create additive or synergistic effects that contribute to insomnia, highlighting the need for careful medication management 6, 7.
If atomoxetine is reintroduced, considering splitting the dose to twice-daily administration, adding a sedating agent, or switching propranolol to an ACE inhibitor or calcium channel blocker may help mitigate insomnia risk 6, 7, 8.